41 – 60 of 65
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Age and diagnostic performance of Alzheimer disease CSF biomarkers
Mattsson, N. ; Rosen, E. ; Hansson, Oskar LU
;
Andreasen, N.
;
Parnetti, L.
;
Jonsson, M.
;
Herukka, S. -K.
;
van der Flier, W. M.
;
Blankenstein, M. A.
and
Ewers, M.
, et al.
(2012)
In Neurology
78(7).
p.468-476
Mark
- 2011
- Preterm birth and risk of epilepsy in Swedish adults
- Neuron-specific enolase correlates with other prognostic markers after cardiac arrest.
- A family with parkinsonism, essential tremor, restless legs syndrome, and depression
- 2010
-
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
Wallin, Å K LU ; Blennow, Kristina ; Zetterberg, H ; Londos, Elisabet LU ; Minthon, Lennart LU and Hansson, Oskar LU
(2010)
In Neurology
74(19).
p.1531-1537
Mark
- The Causative Classification of Stroke system An international reliability and optimization study
- 2008
- Weight loss in Huntington disease increases with higher CAG repeat number
- 2007
- Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
- Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
- 2006
- A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia.
- Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
- 2005
- Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
- Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
- Neutralizing antibodies and efficacy of interferon beta-1a - A 4-year controlled study
- Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
- 2004
- An altered immune response to Epstein-Barr virus in multiple sclerosis - A prospective study
- Ventriculoperitoneal shunting for idiopathic intracranial hypertension.
- 2003
- Carotid dissection with permanent and transient occlusion or severe stenosis: Long-term outcome
- 2002
- Chromosome 3 linked frontotemporal dementia (FTD-3)
- A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS